Why the study?
Do OUES and VE/VCO2 slope identify advanced remodeling and neurohumoral activation in CAD patients with intermediate peakVO2?
Population
214 patients with coronary artery disease (CAD), mean age 67+/-8 years, 85% men.
Design
Cross-sectional
Authors
Loading...
May aid risk stratification in CAD with intermediate peakVO2; leaves open prospective validation before clinical use.
Do OUES and VE/VCO2 slope identify advanced remodeling and neurohumoral activation in CAD patients with intermediate peakVO2?
In CAD patients with intermediate peakVO2, both VE/VCO2 slope and OUES can identify those with more advanced disease remodeling and neurohumoral activation.
Veire et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: